Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Medicines Company

(NASDAQ: MDCO)
Add to Portfolio
+0.27 (+0.52%)
as of 09:13 EST

Last 52.25
Change +0.27 (+0.52%)
Open 52.25
Prev. Close 51.98
Today's Range
52.25
52.25
52wk Range
16.69
58.48
Volume 63,705
Avg Volume 1,470,120
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
MDCO +0.52% +10.56% +164.93%
DJIA +0.80% +4.51% +10.74%
S&P 500 +0.77% +4.76% +14.29%

Key Statistics

Annual EPS -3.10
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 4,334,570
Weighted Alpha +157.26
Standard Deviation +1.11
Profit Margin 25.26%
Beta 0.90

Growth Rates

YTD +172.99%
1-Year +158.61%
3-Year +41.91%
5-Year +102.34%
10-Year +563.01%

Opinion

Sell Hold Buy

Recent Headlines

The Medicines Company Announces that the ORION-9 Study

BusinessWire via COMTEX - 09:00AM EST
--- ORION-9 further demonstrated inclisiran's excellent safety profile, including no treatment-related liver or renal abnormalities(full story)
MDCO: 52.25 (+0.27)

The Medicines Company Announces that the ORION-10

BusinessWire via COMTEX - Sat Nov 16, 10:45AM EST
--- ORION-10 study affirmed inclisiran's excellent safety profile, including no treatment-related liver or renal abnormalities(full story)
MDCO: 52.25 (+0.27)

The Medicines Company to Present Inclisiran Data from

BusinessWire via COMTEX - Wed Nov 06, 04:46PM EST
The Medicines Company (NASDAQ:MDCO) today announced that detailed results from the ORION-9 and ORION-10 pivotal Phase 3 clinical studies of inclisiran will be presented during late-breaking science sessions at the American Heart A(full story)
MDCO: 52.25 (+0.27)

Intra-Cellular T has the Best Relative Performance in

Comtex SmarTrend(R) via COMTEX - Wed Nov 06, 03:41AM EST
Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.(full story)
ITCI: 9.02 (+0.18), MDCO: 52.25 (+0.27), SUPN: 22.08 (+0.25)

The Medicines Company Reports Third-Quarter 2019

BusinessWire via COMTEX - Wed Oct 30, 07:00AM EDT
--- Phase 3 data reinforced durable, potent efficacy and excellent safety(full story)
MDCO: 52.25 (+0.27)